{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:32:58Z","timestamp":1789450378231,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is diagnosed based on chronic anovulation, androgen excess (clinical and\/or biochemical), and polycystic ovaries in ultrasound. The aim of the present study was to evaluate which parameters in the transvaginal ultrasound (TVUS) of ovaries could be better associated with concurrent hormonal imbalance in the women with PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a cross-sectional design, this study focused on 61 subjects (18\u201340 years) with PCOS. Patients were recruited at three academic hospitals during the 2017\u20132019 period. PCOS was defined according to the Rotterdam criteria. The association of ovarian morphology with hormonal and metabolic feature was investigated using linear regression models, adjusted for a set of possible confounding variables including age, mensuration status and body mass index (BMI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean volume of both ovaries was positively associated with the total testosterone level (\u03b2\u2009=\u20090.025, <jats:italic>P<\/jats:italic> value\u2009&lt;\u20090.001), free androgen index (\u03b2\u2009=\u20090.041, <jats:italic>P<\/jats:italic> value\u2009&lt;\u20090.001) and luteinizing hormone\/follicle stimulating hormone (LH\/FSH) ratio (\u03b2\u2009=\u20090.032, <jats:italic>P<\/jats:italic> value\u2009=\u20090.004), even after adjustments made for age, mensuration status and BMI (fully-adjusted model). In contrast, in the fully-adjusted model, antral follicle count (AFC), follicle number per ovary (FNPO), ovarian area, stromal area, and ratio of stromal area to ovarian area (S\/A) were not associated with androgen levels and LH\/FSH ratio. In addition, after full adjustments, ovarian volume, AFC, FNPO, ovarian area, stromal area and S\/A were not associated with insulin resistance, which was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Increased ovarian volume is, thus, highly predictive of hyperandrogenemia and high LH\/FSH ratio in PCOS patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01224-y","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:14:19Z","timestamp":1669918459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome"],"prefix":"10.1186","volume":"22","author":[{"given":"Asieh","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Pejman","family":"Hashemi Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Mohajeri-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Qorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Ghorbani Pashakolaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Sanginabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Mahmoud","family":"Sajjadi-Jazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"5","key":"1224_CR1","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.fertnstert.2014.07.1241","volume":"102","author":"M Youngster","year":"2014","unstructured":"Youngster M, Ward VL, Blood EA, Barnewolt CE, Emans SJ, Divasta AD. Utility of ultrasound in the diagnosis of polycystic ovary syndrome in adolescents. Fertility and Sterility. 2014;102(5):1432\u20138.","journal-title":"Fertility and Sterility"},{"key":"1224_CR2","doi-asserted-by":"crossref","unstructured":"Gerv\u00e1sio CG, Bernuci MP, Silva-de-S\u00e1 MF. Rosa-e-Silva ACJdS. The role of androgen hormones in early follicular development.\u00a0Int Sch Res Not. 2014;2014:818010.","DOI":"10.1155\/2014\/818010"},{"issue":"8","key":"1224_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1701-2163(16)32915-2","volume":"30","author":"ME Lujan","year":"2008","unstructured":"Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynecol Can. 2008;30(8):671\u20139.","journal-title":"J Obstet Gynecol Can"},{"key":"1224_CR4","doi-asserted-by":"crossref","first-page":"204201882093431","DOI":"10.1177\/2042018820934319","volume":"11","author":"P Kempegowda","year":"2020","unstructured":"Kempegowda P, Melson E, Manolopoulos KN, Arlt W, O\u2019Reilly MW. Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Therapeutic Adv Endocrinol Metabolism. 2020;11:2042018820934319.","journal-title":"Therapeutic Adv Endocrinol Metabolism"},{"issue":"3","key":"1224_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/jcm9030732","volume":"9","author":"AM Polak","year":"2020","unstructured":"Polak AM, Adamska A, Krentowska A, \u0141ebkowska A, Hryniewicka J, Adamski M, et al. Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes. Journal of Clinical Medicine. 2020;9(3):732.","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"1224_CR6","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.fertnstert.2015.12.136","volume":"105","author":"HV Brink","year":"2016","unstructured":"Brink HV, Willis AD, Jarrett BY, Lin AW, Soler S, Best S, et al. Sonographic markers of ovarian morphology, but not hirsutism indices, predict serum total testosterone in women with regular menstrual cycles. Fertility and Sterility. 2016;105(5):1322\u20139.","journal-title":"Fertility and Sterility"},{"issue":"63","key":"1224_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.15557\/JoU.2015.0038","volume":"15","author":"M Bachanek","year":"2015","unstructured":"Bachanek M, Abdalla N, Cendrowski K, Sawicki W. Value of ultrasonography in the diagnosis of polycystic ovary syndrome\u2013literature review. J ultrasonography. 2015;15(63):410.","journal-title":"J ultrasonography"},{"issue":"1","key":"1224_CR8","first-page":"1","volume":"3","author":"SP Reid","year":"2017","unstructured":"Reid SP, Kao C-N, Pasch L, Shinkai K, Cedars MI, Huddleston HG. Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study. Fertility Res Pract. 2017;3(1):1\u20137.","journal-title":"Fertility Res Pract"},{"issue":"4","key":"1224_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cen.13380","volume":"87","author":"YA Hong Sh, Sung","year":"2017","unstructured":"Hong Sh, Sung YA, Hong YS, Jeong K, Chung H, Lee H. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome. Clinical Endocrinology. 2017;87(4):375\u201380.","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"1224_CR10","first-page":"1","volume":"7","author":"A Neoklis","year":"2016","unstructured":"Neoklis A, Anastasia K, Damianaki K, Nikolaos D, Markantes G, Papadopoulos V, et al. Polycystic ovarian morphology is Associated with hyperandrogenemia and insulin resistance in women with polycystic ovary syndrome (PCOS). J Steroids Horm Sci. 2016;7(1):1\u20135.","journal-title":"J Steroids Horm Sci"},{"issue":"1","key":"1224_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"B Fauser","year":"2004","unstructured":"Fauser B. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19\u201325.","journal-title":"Fertility and Sterility"},{"issue":"1","key":"1224_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-14-511","volume":"14","author":"S Arentz","year":"2014","unstructured":"Arentz S, Abbott JA, Smith CA, Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo\/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complementary and Alternative Medicine. 2014;14(1):1\u201319.","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"6","key":"1224_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5001\/omj.2012.112","volume":"27","author":"MK Al Kindi","year":"2012","unstructured":"Al Kindi MK, Al Essry FS, Al Essry FS, Mula-Abed W-AS. Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Medical Journal. 2012;27(6):471.","journal-title":"Oman Medical Journal"},{"issue":"6","key":"1224_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0015-0282(00)00501-X","volume":"73","author":"B Kolodziejczyk","year":"2000","unstructured":"Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertility and Sterility. 2000;73(6):1149\u201354.","journal-title":"Fertility and Sterility"},{"key":"1224_CR15","first-page":"1","volume":"4","author":"ZM Ibrahim","year":"2020","unstructured":"Ibrahim ZM, Kishk EA, Fahmy SM, Taha OT. Serum 1, 25-dihydroxy vitamin D-vitamin D3-among obese egyptian women with polycystic ovary syndrome. Obstetrics and Gynecology. 2020;4:1\u20133.","journal-title":"Obstetrics and Gynecology"},{"issue":"9","key":"1224_CR16","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/humrep\/dem202","volume":"22","author":"AM Fulghesu","year":"2007","unstructured":"Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R, et al. Ultrasound in polycystic ovary syndrome\u2014the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Human Reproduction. 2007;22(9):2501\u20138.","journal-title":"Human Reproduction"},{"issue":"2","key":"1224_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2265.2012.04475.x","volume":"78","author":"P Villa","year":"2013","unstructured":"Villa P, Rossodivita A, Sagnella F, Moruzzi MC, Mariano N, Lassandro AP, et al. Ovarian volume and gluco-insulinaemic markers in the diagnosis of PCOS during adolescence. Clinical Endocrinology. 2013;78(2):285\u201390.","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"1224_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0015-0282(97)80068-4","volume":"67","author":"EJ Van Santbrink","year":"1997","unstructured":"Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertility and Sterility. 1997;67(3):452\u20138.","journal-title":"Fertility and Sterility"},{"issue":"8","key":"1224_CR19","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1210\/en.2012-1385","volume":"153","author":"I Ortega","year":"2012","unstructured":"Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, et al. Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt\/PKB signaling pathway. Endocrinology. 2012;153(8):4019\u201329.","journal-title":"Endocrinology"},{"issue":"3","key":"1224_CR20","first-page":"288","volume":"62","author":"BW Rackow","year":"2018","unstructured":"Rackow BW, Brink HV, Hammers L, Flannery CA, Lujan ME, Burgert TS. Ovarian morphology by transabdominal ultrasound correlates with reproductive and metabolic disturbance in adolescents with PCOS. Journal of Adolescent & Adult Literacy. 2018;62(3):288\u201393.","journal-title":"Journal of Adolescent & Adult Literacy"},{"issue":"1","key":"1224_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0377-1237(17)30078-3","volume":"56","author":"J Debnath","year":"2000","unstructured":"Debnath J, Satija L, Suri A, Rastogi V, Dhagat P, Sharma R, et al. Follicular monitoring: comparison of transabdominal and transvaginal sonography. Med J Armed Forces India. 2000;56(1):3\u20136.","journal-title":"Med J Armed Forces India"},{"issue":"2","key":"1224_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5653\/cerm.2014.41.2.86","volume":"41","author":"S Chun","year":"2014","unstructured":"Chun S. Serum luteinizing hormone level and luteinizing hormone\/follicle-stimulating hormone ratio but not serum anti-M\u00fcllerian hormone level is related to ovarian volume in korean women with polycystic ovary syndrome. Clin Experimental Reproductive Med. 2014;41(2):86.","journal-title":"Clin Experimental Reproductive Med"},{"key":"1224_CR23","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol metabolism. 2020;35:100937.","journal-title":"Mol metabolism"},{"issue":"4","key":"1224_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/humrep\/dey017","volume":"33","author":"M Peign\u00e9","year":"2018","unstructured":"Peign\u00e9 M, Catteau-Jonard S, Robin G, Dumont A, Pigny P, Dewailly D. The numbers of 2\u20135 and 6\u20139 mm ovarian follicles are inversely correlated in both normal women and in polycystic ovary syndrome patients: what is the missing link? Human Reproduction. 2018;33(4):706\u201314.","journal-title":"Human Reproduction"},{"issue":"9","key":"1224_CR25","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan Bt, Catteau-Jonard S, Decanter C, Poncelet E, et al. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-mullerian hormone concentrations aggregate with the markers of hyperandrogenism. J Clin Endocrinol Metabolism. 2010;95(9):4399\u2013405.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"1","key":"1224_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.fertnstert.2013.10.001","volume":"101","author":"JP Christ","year":"2014","unstructured":"Christ JP, Willis AD, Brooks ED, Brink HV, Jarrett BY, Pierson RA, et al. Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome. Fertility and Sterility. 2014;101(1):280\u20137.","journal-title":"Fertility and Sterility"},{"issue":"3","key":"1224_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/humrep\/deg115","volume":"18","author":"S Jonard","year":"2003","unstructured":"Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Human Reproduction. 2003;18(3):598\u2013603.","journal-title":"Human Reproduction"},{"key":"1224_CR28","doi-asserted-by":"publisher","first-page":"263349412091303","DOI":"10.1177\/2633494120913032","volume":"14","author":"P Rao","year":"2020","unstructured":"Rao P, Bhide P. Controversies in the diagnosis of polycystic ovary syndrome. Therapeutic Adv Reproductive Health. 2020;14:2633494120913032.","journal-title":"Therapeutic Adv Reproductive Health"},{"issue":"5","key":"1224_CR29","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1210\/jc.2004-0219","volume":"90","author":"RS Legro","year":"2005","unstructured":"Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metabolism. 2005;90(5):2571\u20139.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1224_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2012.07.218","volume":"98","author":"S Pittenger","year":"2012","unstructured":"Pittenger S, Kao C-N, Pasch L, Shinkai K, Huddleston H. Ovarian morphology is associated with insulin resistance: can ovarian volume identify women with metabolic risk in polycystic ovarian syndrome? Fertility and Sterility. 2012;98(3):62.","journal-title":"Fertility and Sterility"},{"issue":"4","key":"1224_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0015-0282(97)81357-X","volume":"67","author":"S Najmabadi","year":"1997","unstructured":"Najmabadi S, Wilcox JG, Acacio BD, Thornton MH, Kolb BA, Paulson RJ. The significance of polycystic-appearing ovaries versus normalappearing ovaries in patients with polycystic ovary syndrome. Fertility and Sterility. 1997;67(4):631\u20135.","journal-title":"Fertility and Sterility"},{"issue":"3","key":"1224_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S0015-0282(16)55797-5","volume":"59","author":"TD Pache","year":"1993","unstructured":"Pache TD, de Jong FH, Hop WC, Fauser BC. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertility and Sterility. 1993;59(3):544\u20139.","journal-title":"Fertility and Sterility"},{"issue":"1","key":"1224_CR33","first-page":"17","volume":"18","author":"MB Mohammad","year":"2017","unstructured":"Mohammad MB, Seghinsara AM. Polycystic ovary syndrome (PCOS), diagnostic criteria, and AMH. Asian Pac J cancer prevention: APJCP. 2017;18(1):17.","journal-title":"Asian Pac J cancer prevention: APJCP"},{"issue":"1","key":"1224_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/uog.18945","volume":"51","author":"MA Coelho Neto","year":"2018","unstructured":"Coelho Neto MA, Ludwin A, Borrell A, Benacerraf B, Dewailly D, da Silva Costa F, et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound in Obstetrics & Gynecology. 2018;51(1):10\u201320.","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"1224_CR35","first-page":"146","volume":"19","author":"K Sujata","year":"2018","unstructured":"Sujata K, Swoyam S. 2D and 3D trans-vaginal sonography to determine cut-offs for ovarian volume and follicle number per ovary for diagnosis of polycystic ovary syndrome in indian women. J Reprod Infertility. 2018;19(3):146.","journal-title":"J Reprod Infertility"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01224-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:15:33Z","timestamp":1669918533000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01224-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01224-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"4 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Helsinki Declaration and was received the approval of the Tehran University of Medical Sciences Ethics Committee (REC.1400.1010). Informed consent was obtained from all patients recruited.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0and Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any conflicts of interest or financial ties to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}